Literature DB >> 3763704

Gait assessment for neurologically impaired patients. Standards for outcome assessment.

M K Holden, K M Gill, M R Magliozzi.   

Abstract

This study compared the temporal-distance (TD) gait values of two groups of neurologically impaired subjects with published TD gait values of healthy subjects and analyzed the influence of nine clinical characteristics on TD values in the neurologically impaired subjects. Velocity, cadence, step length, stride length, and ratio of stride length to lower extremity length were recorded for 37 subjects with hemiparesis and 24 subjects with multiple sclerosis. Temporal-distance values were well below normal values, even in functionally independent subjects. Overall, the subjects with hemiparesis had lower values than the subjects with multiple sclerosis. Of the nine characteristics examined, only diagnosis, etiologic factor (for hemiparesis), type of ambulation aid, and functional category were related significantly to TD values. Our findings suggest that TD gait performance goals for patients with neurological impairment should be based on values from impaired rather than healthy subjects and that these goals should be adjusted for the individual patient's diagnosis, etiologic factor, type of ambulation aid, and functional category.

Entities:  

Mesh:

Year:  1986        PMID: 3763704     DOI: 10.1093/ptj/66.10.1530

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  79 in total

1.  Development of physical performance after acute hip fracture: an observational study in a regular clinical geriatric setting.

Authors:  Davidpremkumar Chandrasekaran; Asa Andersson; Maria Hindenborg; Rolf Norlin; Gunnar Akner
Journal:  Geriatr Orthop Surg Rehabil       Date:  2014-09

2.  Identifying activity levels and steps of people with stroke using a novel shoe-based sensor.

Authors:  George D Fulk; S Ryan Edgar; Rebecca Bierwirth; Phil Hart; Paulo Lopez-Meyer; Edward Sazonov
Journal:  J Neurol Phys Ther       Date:  2012-06       Impact factor: 3.649

3.  Effect of cold application and tizanidine on clonus: clinical and electrophysiological assessment.

Authors:  Ismail Boyraz; Fugen Oktay; Canan Celik; Mufit Akyuz; Hilmi Uysal
Journal:  J Spinal Cord Med       Date:  2009       Impact factor: 1.985

4.  Impact of walking impairment in multiple sclerosis: perspectives of patients and care partners.

Authors:  Nicholas G Larocca
Journal:  Patient       Date:  2011       Impact factor: 3.883

5.  Frailty prevalence and related factors in the older adult-FrailTURK Project.

Authors:  S Eyigor; Y G Kutsal; E Duran; B Huner; N Paker; B Durmus; N Sahin; G M Civelek; K Gokkaya; A Doğan; R Günaydın; F Toraman; T Cakir; D Evcik; A Aydeniz; A G Yildirim; P Borman; M Okumus; E Ceceli
Journal:  Age (Dordr)       Date:  2015-05-07

6.  H-FABP, cardiovascular risk factors, and functional status in asymptomatic spinal cord injury patients.

Authors:  A Akbal; A Kurtaran; B Selçuk; M Akyüz
Journal:  Herz       Date:  2013-03-14       Impact factor: 1.443

7.  Reducing sedentary time and fat mass may improve glucose tolerance and insulin sensitivity in adults surviving 6 months after stroke: A phase I pilot study.

Authors:  Karen N Borschmann; Elif I Ekinci; Sandra Iuliano; Leonid Churilov; Marco Yc Pang; Julie Bernhardt
Journal:  Eur Stroke J       Date:  2017-02-23

8.  Inpatient rehabilitation outcomes in neoplastic spinal cord compression vs. traumatic spinal cord injury.

Authors:  Sevgi Ikbali Afsar; Sacide Nur Saraçgil Cosar; Oya Umit Yemişçi; Hüma Bölük
Journal:  J Spinal Cord Med       Date:  2020-07-23       Impact factor: 1.985

9.  Functionality of patients with post-stroke hemiplegia: Does serum folate level matter?

Authors:  İlke Coşkun Benlidayı; Sibel Başaran
Journal:  Turk J Phys Med Rehabil       Date:  2019-05-03

10.  An innovative training based on robotics for older people with subacute stroke: study protocol for a randomized controlled trial.

Authors:  Elvira Maranesi; Roberta Bevilacqua; Mirko Di Rosa; Giuseppe Pelliccioni; Valentina Di Donna; Riccardo Luzi; Micaela Morettini; Agnese Sbrollini; Elisa Casoni; Nadia Rinaldi; Renato Baldoni; Fabrizia Lattanzio; Laura Burattini; Giovanni R Riccardi
Journal:  Trials       Date:  2021-06-14       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.